Cervidil induction: process, timing, and risks

What does the evidence say about cervidil induction during pregnancy?

1. The current U.S. label specifies one 10-mg vaginal insert for up to 12 hours, releasing about 0.3 mg per hour. Cervidil is administered only by trained obstetric staff in a hospital with appropriate facilities. 1
2. The label requires removal at active labor, 12 hours, before amniotomy, after membrane rupture, or with uterine tachysystole, hypertonicity, or fetal distress. It also requires removal at least 30 minutes before an oxytocic agent and contraindicates use after prior cesarean or major uterine surgery. 1
3. A randomized trial of 336 term inductions compared the Cervidil insert with hospital-formulated prostaglandin E2 gel. Cervical-score change favored the insert, oxytocin use was lower, and labor duration and cesarean differences were not statistically significant. 2
4. In a small randomized trial of 52 first-time mothers at 38 weeks or later, controlled-release dinoprostone pessary produced lower reported pain than repeated gel, while oxytocin and vaginal-birth rates were similar. The small selected sample limits broad prediction of pain. 3
5. A double-blind trial of 1,358 women compared a misoprostol insert with a 10-mg dinoprostone insert. Misoprostol shortened time to delivery but caused more tachysystole requiring intervention, while cesarean rates were similar, so speed alone does not establish the better option for an individual. 4

Is cervidil induction safe in each trimester?

• First trimester. Cervidil's labeled labor-induction use does not apply in the first trimester. Questions about dinoprostone for another obstetric purpose require separate specialist guidance and should not use the term-induction schedule.
• Second trimester. The labeled Cervidil indication is for cervical ripening at or near term when induction is medically or obstetrically indicated. It is not a home method for starting contractions earlier in pregnancy.
• Third trimester. Near term, trained obstetric staff place the insert and monitor contractions, fetal status, and cervical change. The retrieval system lets staff remove it when labor begins or when uterine or fetal findings call for stopping the drug.